Moringa Oleifera Farms and Industries Limited (MOFIL), a hybrid for profit company, has a keen interest in the natural diet supplement market which is a big and complicated one of which Boehringer Ingelheim, being a big pharmaceutical concern, is very conversant with. We will therefore stand to benefit greatly by being led through appropriate product development, manufacturing and marketing backing such with a good raw material base. The natural moringa based food supplement market if well-developed will equally benefit Boehringer with production of new products and distribution channels. A win-win situation will thus be created which will be of great benefit to the two parties and will trickle down to the rural communities we serve.
Distribution Channels, Research and Development, Specific Disease Expertise, Manufacturing, Legal Support, Technology Expertise, Access to Capital.
Research and Development are very important for us to develop new products or improve the existing ones for the markets which are beyond our capacity. Our products focus on various diseases of which, we may require expertise and access to more distribution channels. Some barriers to entering the market include economies of scale, patents, proprietary knowledge and specialized technology which favour large companies. With access to manufacturing, legal support, access to capital and technology expertise, we stand to benefit greatly in a win-win relationship with Boehringer Ingelheim.
Access to and established trust with customers/beneficiaries, Insights into marketing, Insights into distribution, Insights into behavior change.
Improving the affordability of healthcare (e.g., microinsurance, reducing the economic cost of care), Holistic solutions that work across the entire care continuum (including education, prevention, detection, treatment, management, follow-up), Models that engage other industry players (e.g., nutrition, athletic, mobility organizations)., Remote care solutions for health management, treatment, and diagnosis, Packaging of health products and services to address needs currently unmet.